SHS: ouhsc FC - diversity supplement trevor slaney
Ended Awarded Last action
- Contract number
- 75N92022F00002
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $50,147
Award facts
- Contract value 100% obligated
- $50,146.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$21,495 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $9,295 | |
| Original award | $62,347 |
About this award
This federal contract award is a delivery order worth $50,146.86 issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the University of Oklahoma Health Sciences Center. The purpose of this award is to conduct a 15-week study on the use of Interactive Metronome, a computer-based treatment, to improve cognitive functioning in older American Indians with mild cognitive impairment due to cerebrovascular disease. The study involves testing for improvements in Interactive Metronome performance and cognitive functions over the treatment course. Washington State University is a subcontractor on this project. This delivery order is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract the University of Oklahoma holds with the National Cancer Institute for the PREVENT Cancer Preclinical Drug Development Program. There is no set-aside designation for this award.
Quick answers
Who was awarded contract 75N92022F00002?
75N92022F00002 was awarded to University Of Oklahoma by National Heart Lung and Blood Institute (National Institutes of Health) on April 30, 2022.
How much is contract 75N92022F00002 worth?
The government has obligated $50,147 on 75N92022F00002.
Is contract 75N92022F00002 an order under another contract?
Yes. 75N92022F00002 is a delivery order under 75N92019D00028, an indefinite delivery contract.
Was contract 75N92022F00002 competed?
The extent of competition for 75N92022F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award